Sector: Pharmaceuticals & Biotechnology

Small Cap

Balaxi Pharma Share Price

BALAXI

₹24.40

0(0%)

27th Jul 2026 | 3:05 PM

NSE : BALAXI

Open Free Demat Account

Balaxi Pharma Performance

Price Movement

₹24.40

₹24.00

₹24.49

↘ Today's Low↗ Today's High

1 Year Performance

₹24.40

₹15.20

₹52.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹24.49

Low₹24.00

Open at₹24.42

Prev Close₹24.42

Volumes14.06 K

Avg Price₹24.29

Lower Circuit₹0.00

Upper Circuit₹0.00

Historical Performance

3M High₹29.90

3M Low₹22.50

1 Yr High₹52.50

1 Yr Low₹15.20

3 Yr High₹151.45

3 Yr Low₹15.20

5 Yr High₹151.45

5 Yr Low₹15.20

Summary

As of 28-07-2026 02:52, Balaxi Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-24.42 (-100.00%) from the previous close of ₹24.42. The stock opened at ₹24.42 and traded between ₹24 and ₹24.49, with a total traded volume of 14058 shares. The company has a market capitalization of ₹135.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹52.5 and ₹15.2, respectively.

Balaxi Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 95.3, EPS of ₹0.26, and book value of ₹0.50. Profitability indicators show ROE of 0.56%. Balaxi Pharmaceuticals Ltd. has reported revenue of ₹270.17 Cr and net profit of ₹1.42 Cr.

Balaxi Pharmaceuticals Ltd. technical indicators include Day RSI at 56.01, Day MFI at 38.14, Day ADX at 14.39. Additional indicators include Commodity Channel Index (CCI) at 142.3 and Williams %R at -18.33. Momentum indicators show Day MACD at 0.02, Day MACD Signal Line at -0.06, DayATR at 0.93. Rate of Change indicators for Balaxi Pharmaceuticals Ltd. include ROC125 at 3.21 and ROC21 at 5.52.

Exponential moving averages include EMA5 at ₹24.2, EMA10 at ₹24.1, EMA12 at ₹24, EMA20 at ₹24, EMA26 at ₹24, EMA50 at ₹24.1, EMA100 at ₹24.9, EMA200 at ₹30. Simple moving averages include SMA5 at ₹24.1, SMA10 at ₹24, SMA20 at ₹24, SMA30 at ₹23.7, SMA50 at ₹24.2, SMA100 at ₹23.4, SMA150 at ₹23.9, SMA200 at ₹27.8.

Support levels for Balaxi Pharma are placed at First Support ₹24.15, Second Support ₹23.83, Third Support ₹23.66. Resistance levels are seen at First Resistance ₹24.64, Second Resistance ₹24.81, Third Resistance ₹25.13. Balaxi Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 65.99%, FII holding at 0%, DII holding at 0%, public holding at 31.45%.

Balaxi Pharma Fundamentals

Market Cap

Below industry Median

135.10 Cr.

PE Ratio (TTM)

High in industry

95.30

Dividend Yield

Net Profit TTM

94% decr over last year

1.42

Net Profit Growth

94% decr over last year

1.42

PEG Ratio

Negative PEG TTM

-1

ROE

95% decr over last year

0.56

Operating Revenue TTM

270.17

Operating Revenue Growth

8% decr over last year

Book Value

Low in industry

0.50

MFI

MFI is mid-range

38.14

RSI

RSI is mid-range

56.01

EPS (TTM)

0.26

Debt to Equity

0.22

Face Value

Operating Profit Margin Qtr.

3.12

Operating Profit Qtr.

0.12

Net Profit Qtr.

0.61

Operating Revenue Qtr.

70.71

PB Ratio

0.50

Balaxi Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	20.24	24.59	19.31	16.71	9.65
Operating Expense	22.17	23.21	18.54	16.17	10.30
Operating Profit	-1.93	1.38	0.78	0.54	-0.65
Depreciation	0.31	0.15	0.12	0.11	0.11
Interest	0.71	0.73	0.62	0.63	0.69
Tax	0.26	0.59	0.98	0.06	0.04
Net Profit	0.16	1.53	3.26	0.19	-1.18

Balaxi Pharma Technicals

Balaxi Pharmaceuticals Ltd. EMA & SMA

₹24.40

-0.02 (-0.08%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹24.2

Day EMA10 ₹24.1

Day EMA12 ₹24

Day EMA20 ₹24

Day EMA26 ₹24

Day EMA50 ₹24.1

Day EMA100 ₹24.9

Day EMA200 ₹30

Balaxi Pharma Support and Resistance

Resistance

First Resistance₹24.64

Second Resistance₹24.81

Third Resistance₹25.13

Support

First Support₹24.15

Second Support₹23.83

Third Support₹23.66

Technical Indicators

Day RSI56.01

Day MFI38.14

Day ADX14.39

Day Commodity Channel Index142.30

William-18.33

Day MACD0.02

Day MACD Signal Line-0.06

Day ATR0.93

Day ROC1253.21

Day ROC215.52

Balaxi Pharma Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	66	66	66	66	66	66
FII	16	8.9	3.5	1.7	0	0
DII	0	0	0	0.1	2.6	2.6
Public	18	25.1	30.5	32.2	31.4	31.4

Balaxi Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	14.06 K	14.06 K	100.00%
Week	15.81 K	15.81 K	100.00%
1 Month	22.81 K	22.81 K	100.00%
6 Month	70.49 K	91.39 K	77.13%

Balaxi Pharma SWOT Analysis

Strengths12

Weakness12

Opportunity1

Threats0

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

RSI indicating price strength

MACD crossed above zero line previous end of day

Top Gainers

Balaxi Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Balaxi Pharma Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹141.55	₹558	₹5.22	₹111.80	₹160	₹15.84
% Change	2.05%	4.18%	0.77%	-0.18%	-1.84%	5.53%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.88	₹27.81
PE TTM	66.30	-	-0.20	13.10	42.50	28.70
1 Year Return	-0.22	36.63	418	-12.5	29.37	64.95
ROCE	-	3.56	-56.37	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 18.50

-6.33%

INFLUX

Influx Healthtech Ltd.

₹ 285.00

-1.77%

VAISHALI

Vaishali Pharma Ltd.

₹ 7.74

QUESTLAB

Quest Laboratories Ltd.

₹ 93.00

+0.05%

ZENITHDRUG

Zenith Drugs Ltd.

₹ 49.00

-0.51%

ACCENTMIC

Accent Microcell Ltd.

₹ 506.50

+2.33%

SUNREST

Sunrest Lifescience Ltd.

₹ 35.00

+0.00%

MONOPHARMA

Mono Pharmacare Ltd.

₹ 10.50

+0.00%

VILINBIO

Vilin Bio Med Ltd.

₹ 42.60

+4.80%

REMUS

Remus Pharmaceuticals Ltd.

₹ 720.00

+0.06%

INFINIUM

Infinium Pharmachem Ltd.

₹ 214.00

+2.39%

JFLLIFE

JFL Life Sciences Ltd.

₹ 11.45

+0.88%

WALPAR

Walpar Nutritions Ltd.

₹ 34.85

+0.00%

ZOTA

Zota Healthcare Ltd.

₹ 1287.00

+2.27%

BETA

Beta Drugs Ltd.

₹ 2228.00

-3.78%

PAR

Par Drugs & Chemicals Ltd.

₹ 94.21

+0.45%

SAKAR

Sakar Healthcare Ltd.

₹ 829.10

+3.35%

MEDIORG

Medicamen Organics Ltd.

₹ 25.50

+3.24%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 513.10

+0.81%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

+0.81%

SIGACHI

Sigachi Industries Ltd.

₹ 25.94

+1.73%

WINDLAS

Windlas Biotech Ltd.

₹ 861.95

+0.47%

VINEETLAB

Vineet Laboratories Ltd.

₹ 38.88

+0.93%

FAQ's on BALAXI

What is the Market Capitalization of Balaxi Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Balaxi Pharmaceuticals Ltd. is approximately ₹ 135.1 Cr.

What are the PE and PB ratios for Balaxi Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Balaxi Pharmaceuticals Ltd. is 95.3, and the Price-to-Book (PB) ratio is 0.5.

What is the 52-Week High and Low for Balaxi Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Balaxi Pharmaceuticals Ltd. shares was ₹ 52.5, and the lowest price was ₹ 15.2.

Who are the major shareholders of Balaxi Pharmaceuticals Ltd.?

Significant shareholdings in Balaxi Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Balaxi Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Balaxi Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy